Patients Stopping Weight-Loss Medications Put On Weight Four Times Faster Than Those on Conventional Diets

New research indicates that people who come off blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight far faster than those who stop conventional lifestyle plans.

Findings released in a major health publication points out that while overweight people frequently drop substantial amounts of their total mass while on the medication, the weight is regained at an estimated rate of nearly a kilo each month once they quit.

"Users buying these drugs must be informed of the risk of fast weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery means a reversion to pre-treatment weight within about 18 months.

Weighing Therapies

The study, which examined 37 of studies involving thousands of participants, compared the results of these new drugs with other pills.

The team emphasize that individuals who shed pounds through dieting usually see a less rapid creep back—around 100 grams monthly—post-intervention.

Explaining the Fast Rebound

Doctors believe the mechanism of the jabs is key to understanding the heightened weight return.

The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Sustained high doses of GLP-1 concentrations far above than normal could lead to the body to produce less of its own natural GLP-1, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this medication means appetite is unsuppressed, making excessive eating much more probable."

An Ongoing Issue?

The NHS advise the jabs for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Professionals argue that, considering the likelihood of weight regain, the treatment should be considered long-term.

This perspective is reinforced by pharmaceutical companies, who note that the findings "emphasize the persistent character of excess weight," comparing it to managing conditions like diabetes.

User Experiences

People who have come off the jabs explain a powerful resurgence of hunger.

"It felt as if a switch activating and you become extremely hungry," recalled a patient.

This difficulty is exacerbated if users have not established sustainable lifestyle or habit modifications during therapy.

Widespread Interest

Recent estimates show that a significant number of people in the UK have used these injections in the past year, with interest remaining high.

• Adoption is higher among women than men.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, researchers stress that while these medications are powerful tools for weight loss, they are not a permanent fix and lasting health benefits relies on integrated lifestyle changes.